Point72 Asia (Singapore)’s Vigil Neuroscience VIGL Stock Holding History

Point72 Asia (Singapore)’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-24,132	Closed	-$192K	–	1262
2025 Q2	$192K	Buy	24,132 +20,327	+534%	+$91.1K	0.03%	365
2025 Q1	$6.77K	Sell	3,805 -7,031	-65%	-$15.8K	﹤0.01%	762
2024 Q4	$18.4K	Sell	10,836 -851	-7%	-$2.51K	﹤0.01%	682
2024 Q3	$39.7K	Sell	11,687 -10,167	-47%	-$37.7K	0.01%	727
2024 Q2	$87.4K	Buy	+21,854	New	+$74.8K	0.02%	521

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Point72 Asia (Singapore)'s VIGL Position: Q3 2025 in Review

Point72 Asia (Singapore) sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 24,132 shares — an estimated $192K sold.

Point72 Asia (Singapore) first reported a position in VIGL in Q2 2024 and held it in 5 quarters. The position peaked at $192K in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

Point72 Asia (Singapore) reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
Point72 Asia (Singapore) sold 24,132 Vigil Neuroscience shares in Q3 2025, an estimated $192K.
Point72 Asia (Singapore) first reported a position in Vigil Neuroscience in Q2 2024 and held it in 5 quarters.
Point72 Asia (Singapore)'s Vigil Neuroscience position peaked at $192K in Q2 2025.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.